Pediatric Dermatology Clinic now accepting referrals for complex cases - Scorecard - MDSpire

Pediatric Dermatology Clinic now accepting referrals for complex cases

This program provides subspecialty expertise in the diagnosis and management of complex pediatric dermatologic diseases.

  • By

  • May 14, 2026

  • 1 min

Share

Clinical Scorecard: Pediatric Dermatology Clinic now accepting referrals for complex cases

At a Glance

CategoryDetail
ConditionComplex pediatric dermatologic diseases
Key MechanismsFocus on vascular anomalies, genodermatoses, and rare or diagnostically challenging skin disorders
Target PopulationInfants, children, and adolescents
Care SettingTertiary-level, academic care

Key Highlights

  • Led by Maria Gnarra Buethe, MD, PhD
  • Collaboration between UCI Health and Rady Children’s Hospital–Orange County
  • Offers specialized evaluation and advanced diagnostic approaches
  • Serves as a regional referral center for complex cases
  • Accepting referrals for complex pediatric dermatology cases

Guideline-Based Recommendations

Diagnosis

  • Utilize advanced diagnostic approaches for complex cases

Management

  • Implement multidisciplinary management strategies

Monitoring & Follow-up

    Risks

      Patient & Prescribing Data

      Children with complex dermatologic conditions

      Focus on collaboration with community physicians for extended care

      Clinical Best Practices

      • Provide subspecialty expertise in pediatric dermatology
      • Ensure close collaboration between healthcare providers
      • Facilitate referrals for complex cases

      Related Resources & Content

        Original Source(s)

        Pediatric Dermatology Clinic now accepting referrals for complex cases

        • by

        • May 14, 2026

        Related Content

        Combination Therapy Shows Potential in Psoriasis, Obesity

        Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

        Ivarmacitinib Eased Refractory PCA: Case Report

        Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

        Why FDA Said No to a Melanoma Drug

        Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.